JP3841804B2 - 口腔内速崩壊性錠剤用の組成物 - Google Patents

口腔内速崩壊性錠剤用の組成物 Download PDF

Info

Publication number
JP3841804B2
JP3841804B2 JP2004236573A JP2004236573A JP3841804B2 JP 3841804 B2 JP3841804 B2 JP 3841804B2 JP 2004236573 A JP2004236573 A JP 2004236573A JP 2004236573 A JP2004236573 A JP 2004236573A JP 3841804 B2 JP3841804 B2 JP 3841804B2
Authority
JP
Japan
Prior art keywords
weight
parts
composition according
composition
mannitol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2004236573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005139168A (ja
Inventor
伸和 田中
淑郎 長井
博志 川口
忠司 深美
輝正 細川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Chemical Industries Co Ltd
Original Assignee
Fuji Chemical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2004236573A priority Critical patent/JP3841804B2/ja
Application filed by Fuji Chemical Industries Co Ltd filed Critical Fuji Chemical Industries Co Ltd
Priority to PCT/JP2004/013757 priority patent/WO2005037319A1/ja
Priority to EP04292262.5A priority patent/EP1523974B1/en
Priority to IN1264CH2006 priority patent/IN230659B/en
Priority to ES04292262.5T priority patent/ES2694498T3/es
Priority to US10/945,049 priority patent/US7838033B2/en
Priority to KR1020067005251A priority patent/KR101119850B1/ko
Publication of JP2005139168A publication Critical patent/JP2005139168A/ja
Application granted granted Critical
Publication of JP3841804B2 publication Critical patent/JP3841804B2/ja
Priority to US12/908,225 priority patent/US8349361B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2004236573A 2003-10-15 2004-08-16 口腔内速崩壊性錠剤用の組成物 Expired - Lifetime JP3841804B2 (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2004236573A JP3841804B2 (ja) 2003-10-15 2004-08-16 口腔内速崩壊性錠剤用の組成物
EP04292262.5A EP1523974B1 (en) 2003-10-15 2004-09-21 Composition for rapid disintegrating tablet in oral cavity
IN1264CH2006 IN230659B (enExample) 2003-10-15 2004-09-21
ES04292262.5T ES2694498T3 (es) 2003-10-15 2004-09-21 Composición para un comprimido de disgregación rápida en la cavidad oral
PCT/JP2004/013757 WO2005037319A1 (ja) 2003-10-15 2004-09-21 口腔内速崩壊性錠剤用の組成物
US10/945,049 US7838033B2 (en) 2003-10-15 2004-09-21 Composition for rapid disintegrating tablet in oral cavity
KR1020067005251A KR101119850B1 (ko) 2003-10-15 2004-09-21 구강내 속붕해성 정제용 조성물
US12/908,225 US8349361B2 (en) 2003-10-15 2010-10-20 Composition for rapid disintegrating tablet in oral cavity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003355076 2003-10-15
JP2004236573A JP3841804B2 (ja) 2003-10-15 2004-08-16 口腔内速崩壊性錠剤用の組成物

Publications (2)

Publication Number Publication Date
JP2005139168A JP2005139168A (ja) 2005-06-02
JP3841804B2 true JP3841804B2 (ja) 2006-11-08

Family

ID=34380419

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004236573A Expired - Lifetime JP3841804B2 (ja) 2003-10-15 2004-08-16 口腔内速崩壊性錠剤用の組成物

Country Status (7)

Country Link
US (1) US7838033B2 (enExample)
EP (1) EP1523974B1 (enExample)
JP (1) JP3841804B2 (enExample)
KR (1) KR101119850B1 (enExample)
ES (1) ES2694498T3 (enExample)
IN (1) IN230659B (enExample)
WO (1) WO2005037319A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011056775A2 (en) 2009-11-05 2011-05-12 Fmc Corporation Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
KR101159617B1 (ko) * 2003-10-15 2012-06-27 후지카가쿠고교가부시키가이샤 구강내 속붕해성 정제
US8349361B2 (en) * 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
IL169678A (en) 2005-07-14 2010-11-30 Innova Sa Sweetener compositions
KR20130016386A (ko) * 2005-08-10 2013-02-14 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
JP4965096B2 (ja) * 2005-08-19 2012-07-04 テバ製薬株式会社 圧縮成型製剤
WO2007029376A1 (ja) * 2005-09-02 2007-03-15 Fuji Chemical Industry Co., Ltd. 口腔内速崩壊性錠剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP5535616B2 (ja) * 2006-03-31 2014-07-02 ルビコン リサーチ プライベート リミテッド 口腔内崩壊錠剤のための直接圧縮性複合材
SI3103448T1 (sl) * 2006-09-26 2019-11-29 Novartis Ag Farmacevtski sestavek, ki vsebuje modulator S1P
WO2008079342A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
EP2101739A2 (en) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
UY31411A1 (es) * 2007-10-30 2009-05-29 Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados
JP2011513194A (ja) * 2008-02-29 2011-04-28 大塚製薬株式会社 口腔内崩壊錠
JP5572321B2 (ja) * 2008-03-07 2014-08-13 沢井製薬株式会社 被覆微粒子含有口腔内崩壊錠
KR101046789B1 (ko) * 2008-07-16 2011-07-05 동아제약주식회사 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
CA2744377A1 (en) * 2008-11-20 2010-05-27 Avantor Performance Materials, Inc. Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
JP4329947B1 (ja) 2009-01-20 2009-09-09 ライオン株式会社 内服用錠剤
ES2758624T3 (es) * 2009-02-12 2020-05-06 Fuji Chem Ind Co Ltd Composición de partículas desintegrantes y material de desintegración rápida moldeado por compresión que comprende la misma
MX2011009053A (es) 2009-03-09 2012-04-02 Spi Pharma Inc Excipientes de compresion directa con alta capacidad de compactacion y durables y sistemas de excipiente.
GB2495563B (en) * 2009-04-28 2014-12-03 Isp Investments Inc Co-processed excipient compositions
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
US8920839B2 (en) 2009-05-20 2014-12-30 Sumitomo Dainippon Pharma Co., Ltd. Dry-coated orally-disintegrating tablet
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
JP5835875B2 (ja) * 2009-06-29 2015-12-24 富士化学工業株式会社 口腔内速崩壊錠の製造方法
CN102548542B (zh) 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
US8900602B2 (en) 2009-08-11 2014-12-02 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
EP2465539B1 (en) * 2009-08-11 2018-07-11 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
EP2654735B1 (en) 2010-12-22 2016-04-13 Basf Se Rapidly disintegrating, solid coated dosage form
BR112014026292B1 (pt) * 2012-04-24 2022-09-27 Daiichi Sankyo Company, Limited Comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável
CN104487094B (zh) 2012-07-20 2017-05-17 大塚制药株式会社 表面具有干燥油墨被膜的片剂、及用于喷墨打印机的油墨
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
WO2015008825A1 (ja) * 2013-07-19 2015-01-22 株式会社三和化学研究所 口腔内崩壊錠
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
JP6154019B2 (ja) * 2013-10-07 2017-06-28 富士フイルム株式会社 口腔内崩壊錠
US10231476B2 (en) 2014-04-04 2019-03-19 Douxmatok Ltd Sweetener compositions and foods, beverages, and consumable products made thereof
US20160242439A1 (en) 2014-04-04 2016-08-25 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10207004B2 (en) 2014-04-04 2019-02-19 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
RS57328B1 (sr) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Orodisperzibilna dozna jedinica koja sadrži estetrolsku komponentu
NZ737945A (en) 2015-06-18 2023-06-30 Estetra Sprl Orodispersible dosage unit containing an estetrol component
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CR20200486A (es) 2018-04-19 2021-01-27 Estetra Sprl Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110237261A (zh) * 2019-07-30 2019-09-17 珠海市东辰制药有限公司 一种复合崩解剂及其制备方法
CN110840855B (zh) * 2019-11-27 2022-04-12 哈尔滨珍宝制药有限公司 依托考昔片及其制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
MX2022013258A (es) * 2020-04-24 2022-11-14 Astrazeneca Ab Formulaciones farmaceuticas.
WO2022210829A1 (ja) * 2021-04-01 2022-10-06 ニプロ株式会社 アビラテロン酢酸エステル含有錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US75437A (en) * 1868-03-10 Improvement in steaw-cutters
EP0553777B1 (en) 1992-01-29 2002-04-24 Takeda Chemical Industries, Ltd. Fast dissolving tablet and its production
EP0624364B1 (de) * 1993-04-15 1996-07-24 Gerhard Dr. Gergely Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
IL110376A (en) 1993-08-02 1998-08-16 Bristol Myers Squibb Co Pharmaceutical compositions containing ifetroban salts and methods for the preparation thereof
NZ278678A (en) 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
AU694655B2 (en) 1995-05-02 1998-07-23 Taisho Pharmaceutical Co., Ltd. Composition for oral administration
JP2003176242A (ja) 1996-07-12 2003-06-24 Dai Ichi Seiyaku Co Ltd 速崩壊性圧縮成型物及びその製造法
JP3961596B2 (ja) 1996-10-15 2007-08-22 富士化学工業株式会社 無機制酸剤含有速分散性造粒物、その製造方法及び用時懸濁内服制酸剤
JPH11302157A (ja) 1998-04-17 1999-11-02 Eisai Co Ltd 口腔内速崩壊性錠剤
WO1999055373A1 (en) 1998-04-24 1999-11-04 Fuji Chemical Industry Co., Ltd. Saccharide-containing compositions
US20010023252A1 (en) * 1998-07-02 2001-09-20 Smithkline Beecham Plc Novel compound
JP2000086537A (ja) 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
WO2000057857A1 (en) 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6740339B1 (en) * 1999-06-18 2004-05-25 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
JP4588818B2 (ja) 1999-09-16 2010-12-01 日本化学機械製造株式会社 錠剤用賦形剤及び錠剤
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
WO2003030868A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
JP2002128661A (ja) * 2000-10-20 2002-05-09 Chugai Pharmaceut Co Ltd 速崩壊錠剤の製造方法
JP2002154948A (ja) * 2000-11-22 2002-05-28 Eisai Co Ltd 崩壊性に優れた錠剤
CN1494419A (zh) 2001-03-06 2004-05-05 协和发酵工业株式会社 口腔内快速崩解制剂
EP1416922A1 (en) * 2001-07-16 2004-05-12 AstraZeneca AB Pharmaceutical formulation comprising a proton pump inhibitor and antacids
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
EP1488811A1 (en) 2002-03-06 2004-12-22 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011056775A2 (en) 2009-11-05 2011-05-12 Fmc Corporation Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients

Also Published As

Publication number Publication date
IN2006CH01264A (enExample) 2007-06-29
US20050106240A1 (en) 2005-05-19
IN230659B (enExample) 2009-03-27
US7838033B2 (en) 2010-11-23
KR20070018777A (ko) 2007-02-14
KR101119850B1 (ko) 2012-02-28
JP2005139168A (ja) 2005-06-02
ES2694498T3 (es) 2018-12-21
WO2005037319A1 (ja) 2005-04-28
EP1523974A1 (en) 2005-04-20
EP1523974B1 (en) 2018-08-08

Similar Documents

Publication Publication Date Title
JP4726628B2 (ja) 口腔内速崩壊性錠剤
KR101119850B1 (ko) 구강내 속붕해성 정제용 조성물
JP5637624B2 (ja) 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
JP5537943B2 (ja) 速崩壊性固形製剤
JP2001058944A (ja) 速崩壊性固形製剤
WO2011019043A1 (ja) ２種以上の粒子を含有する口腔内速崩壊錠
JP5594285B2 (ja) 口腔内崩壊錠
US8349361B2 (en) Composition for rapid disintegrating tablet in oral cavity
JPWO2009157214A1 (ja) 球状非結晶ケイ酸アルミン酸マグネシウム
JP5074190B2 (ja) 口腔内速崩壊性錠剤
JP5835875B2 (ja) 口腔内速崩壊錠の製造方法
JP5392892B2 (ja) リン酸水素カルシウムからなる球状粒子
CN101227894B (zh) 口腔速崩片
JP2003034655A (ja) 速崩壊性固形製剤
CN100438914C (zh) 用于口腔内快速崩解的片剂的组合物
JP5648265B2 (ja) 錠剤の製造方法
JPWO2000078292A1 (ja) 速崩壊性固形製剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050613

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20050613

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20050707

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060801

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060808

R150 Certificate of patent or registration of utility model

Ref document number: 3841804

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090818

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120818

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120818

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150818

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term